These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist. Tsukada J, Tahara A, Tomura Y, Wada Ki, Kusayama T, Ishii N, Aoki M, Yatsu T, Uchida W, Taniguchi N, Tanaka A. Eur J Pharmacol; 2002 Jun 20; 446(1-3):129-38. PubMed ID: 12098594 [Abstract] [Full Text] [Related]
8. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells. Perdonà E, Arban R, Griffante C. Eur J Pharmacol; 2012 Mar 15; 679(1-3):16-23. PubMed ID: 22285855 [Abstract] [Full Text] [Related]
9. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. Griffante C, Green A, Curcuruto O, Haslam CP, Dickinson BA, Arban R. Br J Pharmacol; 2005 Nov 15; 146(5):744-51. PubMed ID: 16158071 [Abstract] [Full Text] [Related]
11. Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells. Tahara A, Tsukada J, Tomura Y, Momose K, Suzuki T, Yatsu T, Shibasaki M. Eur J Pharmacol; 2006 May 24; 538(1-3):32-8. PubMed ID: 16678155 [Abstract] [Full Text] [Related]
12. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4. Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G. J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136 [Abstract] [Full Text] [Related]
13. In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245). Russell R, Doyle R, Turner J, Attkins N, Ramsey S, Weibley L, Bateman L, Bictash M, Neal-Morgan S, Ivarsson M, Pullen N. Eur J Pharmacol; 2011 Nov 30; 670(2-3):347-55. PubMed ID: 21958878 [Abstract] [Full Text] [Related]
17. Pharmacological characterization of F-180: a selective human V(1a) vasopressin receptor agonist of high affinity. Andrés M, Trueba M, Guillon G. Br J Pharmacol; 2002 Apr 30; 135(7):1828-36. PubMed ID: 11934825 [Abstract] [Full Text] [Related]
19. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. Serradeil-Le Gal C, Herbert JM, Delisee C, Schaeffer P, Raufaste D, Garcia C, Dol F, Marty E, Maffrand JP, Le Fur G. Am J Physiol; 1995 Jan 30; 268(1 Pt 2):H404-10. PubMed ID: 7840290 [Abstract] [Full Text] [Related]